Table of Content



1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 BRIC Generics
2.1. Industry Outlook

3 Generics in Brazil
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators

4 Generics in China
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators

5 Generics in India
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators

6 Generics in Russia
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators

7 Company Profiles
7.1. Sanofi SA
7.2. EMS SA
7.3. Ache Laboratorios Farmaceuticos SA
7.4. Eurofarma Laboratorios SA
7.5. Teva Pharmaceutical Industries Limited
7.6. Mylan N.V.
7.7. China Grand Pharmaceutical and Healthcare Holdings Limited
7.8. Pfizer Inc.
7.9. Sun Pharmaceutical Industries Ltd
7.10. Lupin Ltd
7.11. Aurobindo Pharma Ltd
7.12. Cipla Limited
7.13. Krka, d. d., Novo mesto
7.14. Abbott Laboratories

8 Appendix
8.1. Methodology
8.2. About MarketLine



List of Figures


Figure 1: BRIC generics industry, revenue($m), 2015-24
Figure 2: BRIC generics industry, revenue($m), 2015-19
Figure 3: BRIC generics industry, revenue($m), 2019-24
Figure 4: Brazil generics market value: $ million, 2015–19
Figure 5: Brazil generics market volume: % of total pharma, 2015–19
Figure 6: Brazil generics market geography segmentation: % share, by value, 2019
Figure 7: Brazil generics market value forecast: $ million, 2019–24
Figure 8: Brazil generics market volume forecast: % of total pharma, 2019–24
Figure 9: Forces driving competition in the generics market in Brazil, 2019
Figure 10: Drivers of buyer power in the generics market in Brazil, 2019
Figure 11: Drivers of supplier power in the generics market in Brazil, 2019
Figure 12: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2019
Figure 13: Factors influencing the threat of substitutes in the generics market in Brazil, 2019
Figure 14: Drivers of degree of rivalry in the generics market in Brazil, 2019
Figure 15: China generics market value: $ billion, 2015–19
Figure 16: China generics market volume: % of total pharma, 2015–19
Figure 17: China generics market geography segmentation: % share, by value, 2019
Figure 18: China generics market value forecast: $ billion, 2019–24
Figure 19: China generics market volume forecast: % of total pharma, 2019–24
Figure 20: Forces driving competition in the generics market in China, 2019
Figure 21: Drivers of buyer power in the generics market in China, 2019
Figure 22: Drivers of supplier power in the generics market in China, 2019
Figure 23: Factors influencing the likelihood of new entrants in the generics market in China, 2019
Figure 24: Factors influencing the threat of substitutes in the generics market in China, 2019
Figure 25: Drivers of degree of rivalry in the generics market in China, 2019
Figure 26: India generics market value: $ billion, 2015–19
Figure 27: India generics market volume: % of total pharma, 2015–19
Figure 28: India generics market geography segmentation: % share, by value, 2019
Figure 29: India generics market value forecast: $ billion, 2019–24
Figure 30: India generics market volume forecast: % of total pharma, 2019–24
Figure 31: Forces driving competition in the generics market in India, 2019
Figure 32: Drivers of buyer power in the generics market in India, 2019
Figure 33: Drivers of supplier power in the generics market in India, 2019
Figure 34: Factors influencing the likelihood of new entrants in the generics market in India, 2019
Figure 35: Factors influencing the threat of substitutes in the generics market in India, 2019
Figure 36: Drivers of degree of rivalry in the generics market in India, 2019
Figure 37: Russia generics market value: $ billion, 2015–19
Figure 38: Russia generics market volume: % of total pharma, 2015–19
Figure 39: Russia generics market geography segmentation: % share, by value, 2019
Figure 40: Russia generics market value forecast: $ billion, 2019–24
Figure 41: Russia generics market volume forecast: % of total pharma, 2019–24
Figure 42: Forces driving competition in the generics market in Russia, 2019
Figure 43: Drivers of buyer power in the generics market in Russia, 2019
Figure 44: Drivers of supplier power in the generics market in Russia, 2019
Figure 45: Factors influencing the likelihood of new entrants in the generics market in Russia, 2019
Figure 46: Factors influencing the threat of substitutes in the generics market in Russia, 2019
Figure 47: Drivers of degree of rivalry in the generics market in Russia, 2019


List of Tables


Table 1: BRIC generics industry, revenue($m), 2015-24
Table 2: BRIC generics industry, revenue($m), 2015-19
Table 3: BRIC generics industry, revenue($m), 2019-24
Table 4: Brazil generics market value: $ million, 2015–19
Table 5: Brazil generics market volume: % of total pharma, 2015–19
Table 6: Brazil generics market geography segmentation: $ million, 2019
Table 7: Brazil generics market value forecast: $ million, 2019–24
Table 8: Brazil generics market volume forecast: % of total pharma, 2019–24
Table 9: Brazil size of population (million), 2015–19
Table 10: Brazil gdp (constant 2005 prices, $ billion), 2015–19
Table 11: Brazil gdp (current prices, $ billion), 2015–19
Table 12: Brazil inflation, 2015–19
Table 13: Brazil consumer price index (absolute), 2015–19
Table 14: Brazil exchange rate, 2015–19
Table 15: China generics market value: $ billion, 2015–19
Table 16: China generics market volume: % of total pharma, 2015–19
Table 17: China generics market geography segmentation: $ billion, 2019
Table 18: China generics market value forecast: $ billion, 2019–24
Table 19: China generics market volume forecast: % of total pharma, 2019–24
Table 20: China size of population (million), 2015–19
Table 21: China gdp (constant 2005 prices, $ billion), 2015–19
Table 22: China gdp (current prices, $ billion), 2015–19
Table 23: China inflation, 2015–19
Table 24: China consumer price index (absolute), 2015–19
Table 25: China exchange rate, 2015–19
Table 26: India generics market value: $ billion, 2015–19
Table 27: India generics market volume: % of total pharma, 2015–19
Table 28: India generics market geography segmentation: $ billion, 2019
Table 29: India generics market value forecast: $ billion, 2019–24
Table 30: India generics market volume forecast: % of total pharma, 2019–24
Table 31: India size of population (million), 2015–19
Table 32: India gdp (constant 2005 prices, $ billion), 2015–19
Table 33: India gdp (current prices, $ billion), 2015–19
Table 34: India inflation, 2015–19
Table 35: India consumer price index (absolute), 2015–19
Table 36: India exchange rate, 2015–19
Table 37: Russia generics market value: $ billion, 2015–19
Table 38: Russia generics market volume: % of total pharma, 2015–19
Table 39: Russia generics market geography segmentation: $ billion, 2019
Table 40: Russia generics market value forecast: $ billion, 2019–24
Table 41: Russia generics market volume forecast: % of total pharma, 2019–24
Table 42: Russia size of population (million), 2015–19
Table 43: Russia gdp (constant 2005 prices, $ billion), 2015–19
Table 44: Russia gdp (current prices, $ billion), 2015–19
Table 45: Russia inflation, 2015–19
Table 46: Russia consumer price index (absolute), 2015–19
Table 47: Russia exchange rate, 2015–19
Table 48: Sanofi SA: key facts
Table 49: Sanofi SA: Annual Financial Ratios
Table 50: Sanofi SA: Key Employees